Name | Number of supported studies | Average coverage | |
---|---|---|---|
myofibroblast cell | 6 studies | 20% ± 4% | |
fibroblast | 6 studies | 20% ± 4% | |
pericyte | 6 studies | 31% ± 7% | |
endothelial cell | 6 studies | 27% ± 10% | |
connective tissue cell | 5 studies | 32% ± 9% | |
endothelial cell of lymphatic vessel | 5 studies | 18% ± 2% | |
smooth muscle cell | 4 studies | 22% ± 4% | |
epithelial cell | 3 studies | 23% ± 5% |
Insufficient scRNA-seq data for expression of TEAD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2752.93 | 180 / 180 | 100% | 77.10 | 429 / 430 |
lung | 100% | 3069.68 | 578 / 578 | 95% | 45.93 | 1098 / 1155 |
breast | 100% | 2915.21 | 459 / 459 | 92% | 52.76 | 1027 / 1118 |
uterus | 100% | 3634.08 | 170 / 170 | 91% | 54.20 | 419 / 459 |
pancreas | 100% | 1334.06 | 327 / 328 | 90% | 25.14 | 161 / 178 |
skin | 93% | 945.84 | 1683 / 1809 | 96% | 46.10 | 454 / 472 |
prostate | 100% | 2368.36 | 245 / 245 | 87% | 22.03 | 436 / 502 |
kidney | 100% | 1839.72 | 89 / 89 | 84% | 19.63 | 755 / 901 |
stomach | 100% | 2215.68 | 359 / 359 | 81% | 22.52 | 232 / 286 |
intestine | 100% | 2963.28 | 962 / 966 | 81% | 22.44 | 428 / 527 |
esophagus | 97% | 2614.13 | 1405 / 1445 | 79% | 21.75 | 144 / 183 |
bladder | 100% | 2291.86 | 21 / 21 | 75% | 30.96 | 376 / 504 |
thymus | 100% | 1576.95 | 651 / 653 | 63% | 11.24 | 383 / 605 |
adrenal gland | 100% | 1443.49 | 258 / 258 | 28% | 5.53 | 65 / 230 |
liver | 52% | 441.19 | 117 / 226 | 57% | 18.48 | 232 / 406 |
adipose | 100% | 2618.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2405.99 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 39.00 | 80 / 80 |
heart | 100% | 2563.91 | 860 / 861 | 0% | 0 | 0 / 0 |
spleen | 99% | 1259.46 | 239 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 37.63 | 42 / 45 |
muscle | 74% | 517.95 | 598 / 803 | 0% | 0 | 0 / 0 |
brain | 13% | 69.15 | 356 / 2642 | 39% | 11.35 | 276 / 705 |
lymph node | 0% | 0 | 0 / 0 | 38% | 5.41 | 11 / 29 |
peripheral blood | 1% | 3.37 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0048568 | Biological process | embryonic organ development |
GO_0048368 | Biological process | lateral mesoderm development |
GO_0035329 | Biological process | hippo signaling |
GO_2000736 | Biological process | regulation of stem cell differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0048339 | Biological process | paraxial mesoderm development |
GO_0001570 | Biological process | vasculogenesis |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0001843 | Biological process | neural tube closure |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0003143 | Biological process | embryonic heart tube morphogenesis |
GO_0030903 | Biological process | notochord development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0140552 | Cellular component | TEAD-YAP complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0001223 | Molecular function | transcription coactivator binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0097718 | Molecular function | disordered domain specific binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TEAD2 |
Protein name | TEA domain transcription factor 2 Transcriptional enhancer factor TEF-4 (TEA domain family member 2) (TEAD-2) |
Synonyms | TEF4 |
Description | FUNCTION: Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and epithelial mesenchymal transition (EMT) induction. Binds to the SPH and GT-IIC 'enhansons' (5'-GTGGAATGT-3'). May be involved in the gene regulation of neural development. Binds to the M-CAT motif. . |
Accessions | ENST00000598810.5 [Q15562-4] ENST00000601519.5 [Q15562-2] ENST00000311227.6 [Q15562-1] M0R290 Q15562 M0R1A5 ENST00000598823.5 ENST00000377214.8 [Q15562-2] ENST00000596757.1 ENST00000539846.5 [Q15562-3] ENST00000593945.6 [Q15562-4] |